塞特拉林在精神病和物质使用障碍中的人口药理动力学
Cinthya Eloisa Chávez Castillo1, Susanna Edith Medellín Garibay1, Rosa Del Carmen Milán Segovia1
1Pharmacy Department, Faculty of Chemical Sciences, Autonomous University of San Luis Potosi, San Luis Potosí, Mexico.
Journal of clinical pharmacology
|May 9, 2024
概括
这项研究描述了墨西哥患有精神病和物质使用障碍的患者的塞特拉林药理动力学. 基因因素如CYP2D6*2和CYP2C19显著影响塞特拉林清除,为个性化剂量策略提供信息.
科学领域:
- 药理学 药理学是指药理学的学科.
- 药理动力学 药理动力学
- 精神病学是一个精神病学.
背景情况:
- 塞特拉林是一种被广泛处方的抗抑郁药.
- 人口药理动力学 (PopPK) 对于优化不同患者群体的药物治疗至关重要.
- 墨西哥患有精神病和物质使用障碍的患者代表了PopPK研究的独特人群.
研究的目的:
- 在墨西哥患者中描述塞特拉林的种群药理动力学.
- 为了确定影响塞特拉林药理动学的人口,临床和药理遗传因素.
- 建议优化剂量方案,以改善治疗结果.
主要方法:
- 使用NONMEM软件进行了人群药动力学分析.
- 59名墨西哥患者接受了塞特拉林 (12.5-100毫克/天).
- 分析了血塞特拉林度和遗传多态性 (CYP2D6,CYP2C19).
主要成果:
- 一个单间模型充分描述了塞特拉林度.
- CYP2D6*2多态和CYP2C19表型显著影响了塞特拉林清除.
- CYP2D6*2降低了23.1%的清除率;CYP2C19中间/差表型降低了19.06%/48.26%.
结论:
- 在这种人群中,CYP2D6和CYP2C19的遗传变异是塞特拉林清除的关键决定因素.
- 开发的PopPK模型为个性化的塞特拉林剂量提供了基础.
- 优化剂量可以提高治疗疗效和患者的反应.
相关概念视频
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
126
The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
A study on guinea pigs examined the...
126
Psychosis: Goals of Pharmacotherapy
123
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
123
Antidepressant Drugs: MAOIs and Other Agents
226
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
226
Sedatives and Hypnotics Drugs: Miscellaneous Agents
170
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
170
Substance Use Disorders Affecting Sleep
165
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
165
Analysis of Population Pharmacokinetic Data
252
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
252


